NAHQ Updated CPHQ Exam Questions and Answers by kingsley

The Plan-Do-Study-Act (PDSA) cycle is a systematic series of steps for gaining valuable learning and knowledge for the continual improvement of a product or process. The four stages are:

Plan: Identify an opportunity for improvement and plan a change.

Do: Implement the change on a small scale.

Study: Use data to analyze the results of the change and determine whether it made a difference.

Act: If the change was successful, implement it on a wider scale and continuously assess your results. If the change did not work, begin the cycle again.

In the scenario provided, the team has implemented a new workflow to ensure the correct supplies are available at the start of a procedure. Despite this, a physician reports that key supplies are still missing. This indicates that the change may not have achieved the desired outcome.

The appropriate phase to revisit in this situation is the Study phase. During the Study phase, the team should analyze data and feedback to assess the effectiveness of the implemented change. This involves collecting information on the new workflow's performance, identifying any discrepancies or failures, and understanding why the desired outcome was not achieved. By thoroughly studying the results, the team can gain insights into the shortcomings of the current plan and make informed decisions on necessaryadjustments.

Skipping or inadequately performing the Study phase can lead to the continuation of ineffective processes and prevent the realization of improvement goals. Therefore, revisiting the Study phase is crucial to determine the root causes of the ongoing issue and to inform subsequent actions for improvement.

Safe transitions of care (e.g., from hospital to home or skilled nursing facilities) require robust processes to prevent errors like medication discrepancies or lack of follow-up. An organizational assessment should focus on evaluating these processes comprehensively.

Option A (Review patient feedback about transfers to skilled nursing facilities): Patient feedback provides insights but is limited to perceptions, not a comprehensive process evaluation.

Option B (Assess case management discharge and transfer records): Records show outcomes but do not evaluate the underlying processes driving safety.

Option C (Evaluate processes for discharges and transfers): This is the correct answer. The NAHQ CPHQ study guide states, “To ensure safe transitions of care, quality professionals should evaluate discharge and transfer processes, including communication, medication reconciliation, and follow-up planning” (Domain 5). Tools like process mapping or tracers assess these processes.

Option D (Audit documentation of patient discharge summaries): Auditing documentation is a narrow aspect of transitions, not a full process evaluation.

CPHQ Objective Reference: Domain 5: Population Health and Care Transitions, Objective 5.3, “Assess processes for safe care transitions,” emphasizes evaluating discharge and transfer processes. The NAHQ study guide notes, “Process evaluation ensures safe handoffs and continuity of care” (Domain 5).

Rationale: Evaluating processes provides a comprehensive assessment of transition safety, aligning with CPHQ’s care transition principles.

Clinical pathways (CPWs) are a common component in the quest to improve the quality of health1. They are used to reduce variation, improve quality of care, and maximize the outcomes for specific groups of patients1. The development of a clinical pathway involves a structured multidisciplinary plan of care1. This process includes translating guidelines or evidence into local structures1.

Therefore, during the development of a clinical pathway, a quality professional should consult peer-reviewed evidence. This is because the evidence forms the basis of the guidelines that are translated into the local structures during the development of the clinical pathway1. This ensures that the care provided is based on the most current and best practice, leading to improved patient outcomes2.

It’s important to note that while evaluating peer review committee findings, implementing bestpractice alerts, and gathering patient outcome data can be part of the overall quality improvement process, they are not specifically part of the development of a clinical pathway34. These activities may occur before or after the development of the clinical pathway but are not integral to the development process itself34.